A PROOF OF BIOLOGICAL CONCEPT TRIAL OF CM101 TO TARGET CCL24 IN SYSTEMIC SCLEROSIS: A BIOMARKER INFORMED, PRECISION MEDICINE APPROACH.
| Autor: | Del Galdo, F., Khanna, D., Crater, C., Aricha, R., Lawler, J., Mor, A., Vaknin, I., Frankel, M., Matucci-Cerinic, M. |
|---|---|
| Zdroj: | Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p1616-1617, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|